Expression of NCAPD3 was identified to be correlated with invasion depth (p = 0.009), lymph node metastases (p = 0.029) and pathological TNM stage (p < 0.001) but not with other clinicopathological characteristics in patients with gastric cancer. Here, NCAPD3 is linked to gastric cancer.